Bronchial Clearance Carried Out With a Mechanical In-exsufflator vs. a Manual Respiratory Physiotherapy Technique in Hospitalized Elderly People
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Dec 11, 2024
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for helping older hospitalized patients clear mucus from their lungs, which can be a problem due to bronchial congestion. The two methods being compared are a Mechanical Insufflation-Exsufflation device, which uses a machine to help with breathing and coughing, and a manual technique where a therapist helps the patient to cough. The goal is to see which method is more effective in improving lung function and making it easier for patients to breathe.
To be eligible for this study, participants need to be 60 years or older, currently hospitalized, and have some difficulty with breathing that requires help clearing mucus. They should also be able to understand the study and give their consent to participate. Throughout the trial, participants can expect to receive either of the two treatments and will be monitored for how well they respond. This research is important because effective airway clearance can lead to better outcomes for elderly patients, who often struggle with respiratory issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 60 or over, hospitalized in intensive care or conventional medicine, with bronchial congestion associated with peak expiratory flow \< 180 L/min, justifying respiratory physiotherapy management.
- • Montreal Cognitive Assessment (MoCA) score ≥ 26
- • Able to give consent
- • Membership of a Social Security scheme.
- Exclusion Criteria:
- • Neuromuscular pathologies
- • Spinal cord injury patients
- * Contraindication to the use of a mechanical insufflator:
- • history of bullous emphysema, surgical emphysema, pneumothorax - undrained,
- • recent barotrauma,
- • tracheoesophageal fistula,
- • bronchospasm,
- • hemodynamic instability,
- • Refusal to participate.
- • Inability to cough on command
- • Pregnant and breast-feeding women
- • Persons under curatorship, guardianship, deprivation of liberty or legal protection.
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Lyon, , France
Lyon, , France
Lyon, , France
Patients applied
Trial Officials
Claire Estenne
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported